Results 171 to 180 of about 382,920 (355)

A phase 2 study of bortezomib in relapsed, refractory myeloma.

New England Journal of Medicine, 2003
P. Richardson, B. Barlogie, J. Berenson, S. Singhal, S. Jagannath, D. Irwin, S. Rajkumar, G. Srkalović, M. Alsina, R. Alexanian, David Siegel, R. Orlowski, D. Kuter, S. Limentani, Stephanie L. Lee, T. Hideshima, D. Esseltine, M. Kauffman, Julian Adams, D. Schenkein, K. Anderson   +20 more
semanticscholar   +1 more source

The Histone Modifier KANSL2 Is an Actionable Biomarker in Multiple Myeloma. [PDF]

Mol Cancer Ther
Jiang K, Kirchner M, Herzberg F, Zhao Y, Gasper A, Baumgartner F, Jung P, Braune J, Schulze V, Isaakidis K, Mertins P, Krönke J, Wirth M, Keller U, Habringer S.   +14 more
europepmc   +1 more source

Development of mouse B lymphocyte-myeloma cell hybridomas for production of monoclonal antibodies against HSP-70 of the salamander Plethodon cinereus

, 1991
Zhongmo Yu
openalex   +1 more source

Sensitive Period Analysis of Adulthood BMI and Cancer Risk: An Individual Participant Data Meta‐Analysis of Over 720,000 Participants in the ABACus 2 Consortium

International Journal of Cancer, EarlyView.
Over a dozen cancers have been associated with excess body mass index, primarily in mid‐to‐late adulthood. Whether obesity‐related cancer risk differs across adulthood remains unclear. Using the Sensitive Periods Model and super‐landmarking approaches, this study found that higher BMI increased obesity‐related cancer risk across ages 30–65.
Nadin K. Hawwash, Matthew Sperrin, Glen P. Martin, Rashmi Sinha, Charles E. Matthews, Matthias B. Schulze, Anouk Hiensch, Pilar Amiano, Marian L. Neuhouser, Corinne E. Joshu, Elizabeth A. Platz, Heinz Freisling, Marc J. Gunter, Andrew G. Renehan   +13 more
wiley   +1 more source

P1168: DURABLE REMISSION AFTER SEQUENTIAL CD19/20 CAR T-CELL “CAKE-ICING” THERAPY OCCURRED IN REFRACTORY/RELAPSED DLBCL

HemaSphere, 2023
Peihao Zheng, Fei Xue, Fan Yang, Shaomei Feng, Yuelu Guo, Hui Shi, Guoai Su, Lixia MA, Liu Rui, Biping Deng, Kai Hu, Xiaoyan Ke   +11 more
doaj   +1 more source

MAGa: Monoclonal Autoimmune Gammopathies. [PDF]

Cancers (Basel)
Torres S, Wheeler SE, Shurin MR.
europepmc   +1 more source

Isatuximab (multiple myeloma); Benefit assessment according to §35a SGB V

Institute for Quality and Efficiency in Health Care
openalex   +1 more source

Anti-tumor effect of combining CC chemokine 22 and an anti-CD25 antibody on myeloma cells implanted subcutaneously into mice

, 2009
Koizumi
openalex   +2 more sources

152: Efficacy and toxicity of a second autologous peripheral blood stem cell transplant for patients with relapsed or recurrent multiple myeloma [PDF]

, 2007
Rikesh Patel, J.A. Burzynski, José L. Ochoa-Bayona, Juan J. Toro, Rebecca E. Greene, César O. Freytes   +5 more
openalex   +1 more source

Prognostic Value of Perioperative Anemia in Neurosurgical‐Oncological Treatment of Spinal Metastases

International Journal of Cancer, EarlyView.
High perioperative morbidity in patients undergoing surgery for spinal metastases highlights the need to identify modifiable risk factors, particularly the underexplored role of anemia. This study assessed associations between perioperative hemoglobin levels and complications, recurrence, and mortality in patients treated surgically for spinal ...
Marija Janjic, Logman Khalafov, Juliane Dittmer, Saif‐Eldin Abedellatif, Tim Lampmann, Harun Asoglu, Mohammed Jaber, Haitham Alenezi, Muriel Heimann, Matthias Schneider, Motaz Hamed, Marcus Thudium, Hartmut Vatter, Mohammed Banat   +13 more
wiley   +1 more source